Xeris Biopharma Holdings Inc. buy Jefferies Financial Group Inc.
Start price
03.02.25
/
50%
€3.49
Target price
03.02.26
€5.81
Performance (%)
71.20%
Price
11.12.25
€5.98
Summary
This prediction is currently active. With a performance of 71.20% the BUY prediction by Jefferies_Financial_ is a big success. This prediction currently runs until 03.02.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | 3.463% | 3.463% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Jefferies_Financial_ for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $6.00 price target on the stock, up previously from $4.00.
Ratings data for XERS provided by MarketBeat